<?xml version='1.0' encoding='utf-8'?>
<Document xmlns="urn:iso:std:iso:20022:tech:xsd:pacs.002.001.10"><FIToFIPmtStsRpt><GrpHdr><MsgId>PACS002-ACSC-bebb8380</MsgId><CreDtTm>2025-10-02T10:00:00+00:00Z</CreDtTm></GrpHdr><OrgnlGrpInfAndSts><OrgnlMsgId>PAIN-2025-10-02-Prime_Pharma_SA-baaa9e9c</OrgnlMsgId><OrgnlMsgNmId>pain.001.001.09</OrgnlMsgNmId><GrpSts>PART</GrpSts></OrgnlGrpInfAndSts><OrgnlPmtInfAndSts><OrgnlPmtInfId>PMTINF-2025-10-02-26271b</OrgnlPmtInfId><TxInfAndSts><StsId>STS-2915e651</StsId><OrgnlInstrId>INST-20251002-01054</OrgnlInstrId><OrgnlEndToEndId>E2E-20251002-01054</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-02T10:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="EUR">9117.27</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-667178ad</StsId><OrgnlInstrId>INST-20251002-01086</OrgnlInstrId><OrgnlEndToEndId>E2E-20251002-01086</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-02T10:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="AUD">244408.71</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-948166ae</StsId><OrgnlInstrId>INST-20251002-01121</OrgnlInstrId><OrgnlEndToEndId>E2E-20251002-01121</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-02T10:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="GBP">789.37</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts></OrgnlPmtInfAndSts></FIToFIPmtStsRpt></Document>